Product Images Gabapentin

Calculate creatinine clearance (CLCr) for female patients by multiplying their serum creatinine (in mg/dL) by 0.85 and then by 72. The value of 140 is not clear, so it is not possible to provide a useful description based on this text.*

The text describes a study or experiment in which a "Mean Pain Score" of 10 is shown. It also shows a "4-Week Dose Titration Period" and a "4-Week Fixed Dose Period" on a chart, with a "Placebo" and a "Gabapentin, 3600 mg/day" line plotted. The rest of the text is not readable as it contains non-English characters.*

This appears to be a chart or table displaying the mean pain scores for different treatments over a period of time. The table includes four different periods: baseline, week 1, week 4, and a fixed dose period of unknown length. The treatments being compared are placebo, and two doses of gabapentin (1800mg/day and 2400mg/day). No further context or explanation is available.*

The text is showing a chart titled "Proportion of Responders" with values ranging from 0% to 100%. There is mention of pain reduction scores and studies related to PHN (postherpetic neuralgia). There are percentages provided under the "Study" column, and under other columns, there are different values such as "GBP 3600", "GBP 1800" and "GBP 2400". There is also a note about p-values.*

This appears to be a medication packaging label for a 600mg tablet of a drug named "Neurontin". It was packaged by Bryant Ranck Prepack and is being compared to a similar product made by Alkem Laboratories Limited. The package contains 30 tablets and has an expiration date of MM/YY. The package should be stored at room temperature between 20 and 25 degrees Celsius. The label also includes the drug's NDC number and some contact information for the manufacturer. It reminds users to keep all drugs out of reach of children.*